Mereo BioPharma Group plc
MREO
$2.30
$0.177.98%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 69.80M | 80.52M | 87.43M | 48.66M | 57.42M |
| Total Receivables | 2.79M | 2.37M | 2.02M | 1.65M | 3.13M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 330.00K | 1.77M | 1.76M | 2.24M | 972.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.85M | 2.06M | 2.73M | 949.00K | 2.23M |
| Total Current Assets | 74.76M | 86.72M | 93.94M | 53.50M | 63.76M |
|
|
|||||
| Total Current Assets | 74.76M | 86.72M | 93.94M | 53.50M | 63.76M |
| Net Property, Plant & Equipment | 984.00K | 1.22M | 1.32M | 1.47M | 1.65M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 643.00K | 799.00K | 866.00K | 972.00K | 1.09M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 76.39M | 88.75M | 96.13M | 55.94M | 66.50M |
|
|
|||||
| Total Accounts Payable | 2.68M | 1.98M | 3.50M | 2.46M | 2.35M |
| Total Accrued Expenses | 4.57M | 5.58M | 6.02M | 2.93M | 5.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.24M | 6.29M | 5.61M | 5.29M | 652.00K |
| Total Finance Division Other Current Liabilities | 357.00K | 358.00K | 334.00K | 327.00K | 741.00K |
| Total Other Current Liabilities | 357.00K | 358.00K | 334.00K | 327.00K | 741.00K |
| Total Current Liabilities | 13.85M | 14.21M | 15.47M | 11.00M | 9.49M |
|
|
|||||
| Total Current Liabilities | 13.85M | 14.21M | 15.47M | 11.00M | 9.49M |
| Long-Term Debt | -- | -- | -- | -- | 4.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 187.00K | 394.00K | 552.00K | 727.00K | 906.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.39M | 1.61M | 1.46M | 1.37M | 1.18M |
| Total Liabilities | 15.42M | 16.21M | 17.48M | 13.10M | 15.96M |
|
|
|||||
| Common Stock & APIC | 542.70M | 539.48M | 537.76M | 489.70M | 488.88M |
| Retained Earnings | -462.88M | -455.84M | -440.84M | -428.58M | -419.63M |
| Treasury Stock & Other | -18.85M | -11.10M | -18.28M | -18.28M | -18.72M |
| Total Common Equity | 60.97M | 72.54M | 78.65M | 42.84M | 50.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 60.97M | 72.54M | 78.65M | 42.84M | 50.54M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 60.97M | 72.54M | 78.65M | 42.84M | 50.54M |
|
|
|||||